The Universities of Heidelberg (Germany) and Groningen (the Netherlands) in cooperation with Sanofi are jointly opening up an International Graduate School with the scientific focus on Diabetic Microvascular Complications (DIAMICOM).

We provide scientific staffing services on a temporary, temp to hire, and full-time basis to a broad spectrum of industries including Chemical, Environmental, Food Science, Pharmaceutical, and Biotechnology.

We are currently offering a PhD position for recent graduates (Foreign nationals only! with Master of Science in biology, chemistry, pharmaceutical sciences or similar) who are interested in ion channel research, in particular in TRPML cation channels (mucolipins) and two-pore channels (TPCs).

The Immune regulation group at the DRFZ is looking for a scientific assistant.

The group of Alexander Bird at the Max Planck Institute for Molecular Physiology (Dortmund) is looking for highly motivated PhD students interested in investigating of the function and regulation of microtubule networks in mammalian systems.

Ph.D. position available at the Max Planck Institute of Molecular Physiology: Control of meiotic DNA break formation

The University of Regensburg and the Bavarian Center for Molecular Biosystems (BioSysNet) is inviting applications for PhD and Postdoc positions in post-transcriptional regulation of gene Expression BioSysNet (www.biosysnet.de) pools and strengthens biosystems research in Bavaria, including a networ...

The Australian Infectious Disease Research Centre (AID) was established to link molecular microbiological and clinical expertise and to interconnect the various Schools and Institutes at the University of Queensland and at the Queensland Institute of Medical Research through collaboration and techno...

The Medical University of Graz invites applications for 6 positions in the excellence PhD program “Molecular Fundamentals of Inflammation” (DK-MOLIN).

The PhD student will investigate disease mechanisms and novel therapeutic strategies in cystic fibrosis and related chronic inflammatory lung diseases. Studies will include pharmacologic and cell based approaches in cultured cells, animal models and tissues from CF patients.